Redhill Biopharma
RDHL · NASDAQ
$0.5073−$0.0023 (−0.45%)TodayMarket closed ·
Prev close $0.5096
Who owns RDHL
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 0.0% of RDHL’s shares.
- Yorkville Advisors Global, LP.0.0%
- Gagnon Securities LLC0.0%
- Citadel Advisors LLC0.0%
- Rhumbline Advisers Ltd. Partnership0.0%
- Next 6 largest institutions0.0%
- All other shareholders100.0%
| Holder | Shares | % of shares |
|---|---|---|
| Yorkville Advisors Global, LP. | 122.13K | 0.00% |
| Gagnon Securities LLC | 88.41K | 0.00% |
| Citadel Advisors LLC | 65.32K | 0.00% |
| Rhumbline Advisers Ltd. Partnership | 13.76K | 0.00% |
| Lido Advisors, LLC | 11.01K | 0.00% |
| GAMMA Investing LLC | 6.96K | 0.00% |
| Citi Investment Research (US) | 4.38K | 0.00% |
| Desjardins Securities Inc. | 3.39K | 0.00% |
| RBC Dominion Securities, Inc. | 351 | 0.00% |
| UBS Financial Services, Inc. | 84 | 0.00% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders sold $2.84K (2 trades) of RDHL on the open market, with no buys.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Raday Gilead | Option exercise | 27.56M | — |
| Raday Gilead | Sale | 14.31M | $1.43K |
| Raday Gilead | Option exercise | 28.15M | — |
| Raday Gilead | Sale | 14.13M | $1.41K |
Short interest
Settled Sep 30, 2026
- Shares short
- 211.20K
- Days to cover
- 1.57
- % of shares outstanding
- 0.00%
- Average daily volume
- 134.66K
- Change since last report
- −10.2%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.